SSScott A. Saracco

Scott A. Saracco

*This is an algorithmically generated author record based on publicly available information.

Scott A. Saracco has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Safety Assessment of Newly Expressed Proteins in Genetically Modified Crops: A Decade of Regulatory Case Studies

    by Cunxi Wang, Christopher R. Brown, Tommi A. White, Beverly F. Anderson, Yong Yin, Harit K. Bal, Collin J. Preftakes, Rong Wang, Scott A. Saracco, Kimberly Hodge-Bell, et al.

    This review synthesizes regulatory and scientific evidence accumulated over the past decade supporting the safety of newly expressed proteins (NEPs) in genetically modified (GM) crops. Using five case studies representing diverse protein classes, including dicamba monooxygenase (DMO), protoporphyrinogen IX oxidase (PPO), Cry1B.2/Cry1B.3, Mpp75Aa1.1, and Vip3Cb1, it illustrates how science-based, case-by-case, weight-of-evidence approaches are applied in food and feed safety assessment and ecological risk assessment (ERA) for regulatory submissions. These examples demonstrate how hazard identification, hazard characterization, and exposure assessment are integrated across proteins with diverse biological functions, structural characteristics, and levels of familiarity. It further examines the safety relevance of protein processing and sequence variation arising from protein engineering or biological processing and discusses the scientific basis supporting bridging and read-across approaches, including phylogenetic relationships, sequence similarity, structural conservation, domain architecture, and functional equivalence. The increasing application of safe-by-design principles and bridging strategies is highlighted as an important advancement enabling efficient, scientifically robust evaluations while reducing unnecessary testing. The review also discusses the convergence of food/feed safety assessment and ERA and future directions. Overall, accumulated evidence from NEPs commercialized to date in GM crops has not identified hazards for the assessed safety endpoints and supports the continued evolution and modernization of protein safety assessment frameworks.

  • Open Access

    Safety Assessment of Newly Expressed Proteins in Genetically Modified Crops: A Decade of Regulatory Case Studies

    by Cunxi Wang, Christopher R. Brown, Tommi A. White, Beverly Anderson, Yong Yin, Harit Kaur Bal, Collin J. Preftakes, Rong Wang, Scott Saracco, Kimberly Hodge-Bell, et al.

    This review synthesizes regulatory and scientific evidence accumulated over the past decade supporting the safety of newly expressed proteins (NEPs) in genetically modified (GM) crops. Using five case studies representing diverse protein classes, including dicamba monooxygenase (DMO), protoporphyrinogen IX oxidase (PPO), Cry1B.2/Cry1B.3, Mpp75Aa1.1, and Vip3Cb1, it illustrates how science-based, case-by-case, weight-of-evidence approaches are applied in food and feed safety assessment and ecological risk assessment (ERA) for regulatory submissions. These examples demonstrate how hazard identification, hazard characterization, and exposure assessment are integrated across proteins with diverse biological functions, structural characteristics, and levels of familiarity. It further examines the safety relevance of protein processing and sequence variation arising from protein engineering or biological processing and discusses the scientific basis supporting bridging and read-across approaches, including phylogenetic relationships, sequence similarity, structural conservation, domain architecture, and functional equivalence. The increasing application of safe-by-design principles and bridging strategies is highlighted as an important advancement enabling efficient, scientifically robust evaluations while reducing unnecessary testing. The review also discusses the convergence of food/feed safety assessment and ERA and future directions. Overall, accumulated evidence demonstrates that NEPs in commercialized GM crops have not introduced safety concerns and supports the continued evolution and modernization of protein safety assessment frameworks.